<?xml version="1.0" encoding="UTF-8"?>
<ref id="B42-vaccines-08-00036">
 <label>42.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Arroyo</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Miller</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Catalan</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Myers</surname>
    <given-names>G.A.</given-names>
   </name>
   <name>
    <surname>Ratterree</surname>
    <given-names>M.S.</given-names>
   </name>
   <name>
    <surname>Trent</surname>
    <given-names>D.W.</given-names>
   </name>
   <name>
    <surname>Monath</surname>
    <given-names>T.P.</given-names>
   </name>
  </person-group>
  <article-title>ChimeriVax-West Nile virus live-attenuated vaccine: Preclinical evaluation of safety, immunogenicity, and efficacy</article-title>
  <source>J. Virol.</source>
  <year>2004</year>
  <volume>78</volume>
  <fpage>12497</fpage>
  <lpage>12507</lpage>
  <pub-id pub-id-type="doi">10.1128/JVI.78.22.12497-12507.2004</pub-id>
  <pub-id pub-id-type="pmid">15507637</pub-id>
 </element-citation>
</ref>
